Cirdan Imaging Raises £2.3M to Expand Digital Pathology
Congrats Stephen Dunniece🚀 Cirdan raised £2,300,000 in a remarkable funding round.
Cirdan Imaging, a Lisburn, Northern Ireland, UK-based digital pathology company, recently announced that it has raised £2.3M in funding. The funding round was led by Kernel Capital through the Bank of Ireland Kernel Capital Growth Fund (NI), with participation from other investors including Clarendon Fund Managers and private investors. With this new capital infusion, Cirdan Imaging plans to onboard new customers and accelerate its operational expansion.
Under the leadership of Stephen Dunniece, Cirdan Imaging offers diagnostic digital health and imaging solutions that significantly improve patient clinical pathways and pathology laboratory work.
The company's comprehensive platform, which encompasses specimen imaging solutions, patient and clinician apps, and a Laboratory information system, efficiently and swiftly gathers critical information to help shorten the time required for diagnosis. Additionally, it provides invaluable insights into healthcare data. The platform seamlessly integrates with digital pathology and AI, thereby augmenting efficiency, agility, control, and visibility.
Headquartered in the UK, Cirdan Imaging has established offices in North America and Australia and is undergoing a remarkable period of growth. This growth is expected to continue as the company expands its product line with innovative offerings and taps into new international markets. Currently, Cirdan Imaging's impressive client base spans across more than 150 laboratories and hospitals in 20 countries and 6 continents.
They've invested in Cirdan
Get to know these Healthtech investors
Click here for a full list of 6,528+ startup investors in the UK